The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Dow Chemical's revenues will decrease -2.7% and EPS will increase 44.0%.
The average estimate for revenue is $13.71 billion. On the bottom line, the average EPS estimate is $0.36.
Last quarter, Dow Chemical notched revenue of $13.64 billion. GAAP reported sales were 9.7% lower than the prior-year quarter's $15.11 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at $0.42. GAAP EPS of $0.42 for Q3 were 39% lower than the prior-year quarter's $0.69 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 16.8%, 220 basis points better than the prior-year quarter. Operating margin was 7.4%, 80 basis points better than the prior-year quarter. Net margin was 4.3%, 170 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $56.54 billion. The average EPS estimate is $1.92.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 2,102 members out of 2,232 rating the stock outperform, and 130 members rating it underperform. Among 646 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 631 give Dow Chemical a green thumbs-up, and 15 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Dow Chemical is hold, with an average price target of $33.87.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Dow Chemical. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Dow Chemical to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
3 Large-Cap Stocks to Buy in February
These three companies have made investors millions. Here's why they'll keep doing so.
Will These Megamergers Gain Approval in 2017?
Low commodity prices have led to a wave of consolidation in agricultural industries. This year could make or break $186 billion in deals.
Did Warren Buffett Manipulate the Market in Dow Chemical Stock?
Some call it manipulation. This Fool calls it smart investing.